A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : SD / solid dispersion

[Related PubMed/MEDLINE]
Total Number of Papers: 222
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   SD  (>> Co-occurring Abbreviation)
Long Form:   solid dispersion
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Formulation strategy of nitrofurantoin: co-crystal or solid dispersion? ATR-FTIR, DSC, HPMC, NF
2020 Preparation and evaluation of a novel solid dispersion using leucine as carrier. Leu, OA
2020 Solubilization of phloretin via steviol glycoside-based solid dispersion and micelles. MC, PT, SA, STE
2019 Amorphous multi-system of celecoxib improves its anti-inflammatory activity in vitro and oral absorption in rats. BA, CXB, DW, SLS
2019 Comparison of paclitaxel solid dispersion and polymeric micelles for improved oral bioavailability and in vitro anti-cancer effects. BA, MDCK line, PTX, TPGS
2019 Design of Coenzyme Q10 solid dispersion for improved solubilization and stability. CQ10
2019 Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization. BCRP, DSC, FTIR, SEM, XRPD
2019 Drug-polymer miscibility, interactions, and precipitation inhibition studies for the development of amorphous solid dispersions for the poorly soluble anticancer drug flutamide. FLT, MDSC, PM, PXRD
2019 Effect of Carrier Lipophilicity and Preparation Method on the Properties of Andrographolide⁻Solid Dispersion. AG, PEG, Tm
10  2019 Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and in vivo studies. ARI, DSC, HME, SA, SEM, XRD
11  2019 Highly Water-Soluble Solid Dispersions of Honokiol: Preparation, Solubility, and Bioavailability Studies and Anti-Tumor Activity Evaluation. AGJ, AIJ, HK, PLX
12  2019 Improvement of the dissolution rate and bioavailability of fenofibrate by the supercritical anti-solvent process. AUC, CSE, SAS
13  2019 Improving solubility and dissolution of meloxicam by solid dispersion using hydroxypropyl methylcellulose 2910 3 cps and nicotinamide. DTA, HPMC, MLX, NC, PXRD, SEM
14  2019 Insight into the Dissolution Molecular Mechanism of Ternary Solid Dispersions by Combined Experiments and Molecular Simulations. DSC, GLI, IR, MD, SEM, XRD
15  2019 Naftopidil-fumaric acid interaction in a solid dispersion system: Improving the dissolution rate and oral absorption of naftopidil in rats. NAF
16  2019 Predicting physical stability of solid dispersions by machine learning techniques. ED, RF
17  2019 Preparation of Liquid Oral Mucoadhesive Gastro-retentive System of Nimodipine. ---
18  2019 Preparation, characterization and ex vivo-in vivo assessment of candesartan cilexetil nanocrystals via solid dispersion technique using an alkaline esterase activator carrier. CC
19  2019 Preparation, physicochemical and pharmacological study of curcumin solid dispersion with an arabinogalactan complexation agent. AG, CUR, GPC
20  2019 Solid Dispersion of Kaempferol: Formulation Development, Characterization, and Oral Bioavailability Assessment. AUC, DSC, FTIR, KPF, SEM, XRD
21  2019 Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. H-bond, HME, LPV, P-gp
22  2019 T2 Relaxation Study to Evaluate the Crystalline State of Indomethacin Containing Solid Dispersions Using Time-Domain NMR. APIs, IMC, PM, PVP, TD-NMR
23  2019 Ternary solid dispersion to improve solubility and dissolution of meloxicam. HPMC, MLX, NA
24  2018 Application of scCO2 technology for preparing CoQ10 solid dispersion and SFC-MS/MS for analyzing in vivo bioavailability. DSC, PXRD, SEM
25  2018 Association of Silver Nanoparticles and Curcumin Solid Dispersion: Antimicrobial and Antioxidant Properties. CUR
26  2018 Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin. CUR, HPMC K4M, PVP-K30
27  2018 Dissolution and oral bioavailability enhancement of praziquantel by solid dispersions. AUCs, FTIR, PZQ, SDS, XRD
28  2018 Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation. CETP, SMEDDS
29  2018 Encapsulation of Solid Dispersion in Solid Lipid Particles for Dissolution Enhancement of Poorly Water-Soluble Drug. SDSLs, SLs
30  2018 Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions. ASDs, AUC, BNZ, PCZ
31  2018 Enhancement of Aqueous Solubility and Dissolution of Celecoxib through Phosphatidylcholine-Based Dispersion Systems Solidified with Adsorbent Carriers. CLC, FT-IR, PC
32  2018 Enhancement of lymphatic transport of lutein by oral administration of a solid dispersion and a self-microemulsifying drug delivery system. SMEDDS
33  2018 HPMCAS as an effective precipitation inhibitor in amorphous solid dispersions of the poorly soluble drug candesartan cilexetil. CC, HPMC, HPMCAS
34  2018 Identification of molecular-interaction sites between lowly hydrolyzed polyvinyl alcohols and indomethacin by NMR spectroscopy. IND, NOESY, PVAs
35  2018 Molecular-level elucidation of saccharin-assisted rapid dissolution and high supersaturation level of drug from Eudragit E solid dispersion. EUD-E, PHT, SAC
36  2018 Preparation and comparison of tacrolimus-loaded solid dispersion and self-microemulsifying drug delivery system by in vitro/in vivo evaluation. HPMC, SMEDDS
37  2018 Preparation of curcumin self-micelle solid dispersion with enhanced bioavailability and cytotoxic activity by mechanochemistry. CUR
38  2018 Preparation of lapatinib ditosylate solid dispersions using solvent rotary evaporation and hot melt extrusion for solubility and dissolution enhancement. DSC, DT, HME, LB, PXRD, SEM, SRE
39  2018 Preparation, characterization and in vitro and in vivo evaluation of a solid dispersion of Naringin. FT-IR, NA
40  2018 Solid dispersion of dutasteride using the solvent evaporation method: Approaches to improve dissolution rate and oral bioavailability in rats. ATR FT-IR, BA, DSC, DUT, FESEM, MCC, PXRD, SLS, TPGS
41  2018 Solid dispersions to enhance the delivery of a potential drug candidate LPSF/FZ4 for the treatment of schistosomiasis. ---
42  2018 Synchronized release of bufadienolides in a stable Lutrol F127 based solid dispersion prepared with spray congealing. ---
43  2017 Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium. FDC, MgO, PEG 6000, PRA, TEL
44  2017 Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate. BCS, DW, FT-IR, SLS, TDF
45  2017 Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions. DSC, MLX, ODTs, PVP k30, SLS, XRD
46  2017 Development of a binary carrier system consisting polyethylene glycol 4000 - ethyl cellulose for ibuprofen solid dispersion. API, ATR-FTIR, DSC, EC, PEG, SDP, SEM
47  2017 Development, Physicochemical Characterization and In Vitro Anti-Inflammatory Activity of Solid Dispersions of alpha,beta Amyrin Isolated from Protium Oilresin. ABAM, DSC, FTIR, HPMC, KND, PM, RE, SEM, TG, XRD
48  2017 Enhancement of solubility and dissolution rate of baicalein, wogonin and oroxylin A extracted from Radix scutellariae. VC
49  2017 Enhancement of the aqueous solubility and permeability of a poorly water soluble drug ritonavir via lyophilized milk-based solid dispersions. DSC, FTIR, PXRD, RTV, SEM
50  2017 Ginger Extract-Loaded Solid Dispersion System with Enhanced Oral Absorption and Antihypothermic Action. GE, GE
51  2017 Improved Dissolution of Dipyridamole with the Combination of pH-Modifier and Solid Dispersion Technology. DP, TA
52  2017 Polymeric behavior evaluation of PVP K30-poloxamer binary carrier for solid dispersed nisoldipine by experimental design. SDnisol
53  2017 Role of P-Glycoprotein Inhibitors in the Bioavailability Enhancement of Solid Dispersion of Darunavir. DoE, DRV
54  2017 Surface Solid Dispersion and Solid Dispersion of Meloxicam: Comparison and Product Development. CPV, MLX, SSD
55  2017 Tadalafil solid dispersion formulations based on PVP/VA S-630: Improving oral bioavailability in rats. BA, TDF
56  2016 A comparative study on the effects of amphiphilic and hydrophilic polymers on the release profiles of a poorly water-soluble drug. DL, FEN, PF127
57  2016 A silica-supported solid dispersion of bifendate using supercritical carbon dioxide method with enhanced dissolution rate and oral bioavailability. DSC, RH, XRD
58  2016 Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant. EOP, HME
59  2016 Atorvastatin solid dispersion for bioavailability enhancement. AT
60  2016 Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. ATR-FTIR, DSC, ITZ, PXRD
61  2016 Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis. CS, NIMs, NPs
62  2016 Development and evaluation of solid dispersion of spironolactone using fusion method. API, PEG 4000, SPL
63  2016 Development and Optimization of Controlled Porosity Osmotic Tablets of Lamotrigine Solid Dispersion. CPOT
64  2016 Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution. ---
65  2016 Enhancement of Dissolution Rate and Intestinal Stability of Clopidogrel Hydrogen Sulfate. ---
66  2016 Evaluation of physicochemical properties and in vivo efficiency of atorvastatin calcium/ezetimibe solid dispersions. ATV, DSC, EZT, PMs, PXRD, TC
67  2016 Extruded Soluplus/SIM as an oral delivery system: characterization, interactions, in vitro and in vivo evaluations. HME, PMs, SIM
68  2016 Formulation of cyclodextrin inclusion complex-based orally disintegrating tablet of eslicarbazepine acetate for improved oral bioavailability. beta-CD, DSC, ESL, FTIR, ODT, XRD
69  2016 Hydrophilic-hydrophobic polymer blend for modulation of crystalline changes and molecular interactions in solid dispersion. ---
70  2016 Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate. HPMC, SLS
71  2016 Investigation of Polymer-Surfactant and Polymer-Drug-Surfactant Miscibility for Solid Dispersion. ---
72  2016 Optimized sildenafil citrate fast orodissolvable film: a promising formula for overcoming the barriers hindering erectile dysfunction treatment. ODF
73  2016 Physical characterization and dissolution performance assessment of Etravirine solid dispersions prepared by spray drying process. ANOVA, DSC, FTIR, MDT, SEM
74  2016 Preparation and characterization of dipyridamole solid dispersions for stabilization of supersaturation: effect of precipitation inhibitors type and molecular weight. DPL, HPMC, PVP
75  2016 Sodium alginate as a potential carrier in solid dispersion formulations to enhance dissolution rate and apparent water solubility of BCS II drugs. SA, TEL
76  2016 Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions. FEL, SOL
77  2016 Solubilization and formulation of chrysosplenol C in solid dispersion with hydrophilic carriers. CRSP, DSC, FTIR, SEM, SLS, XRD
78  2016 The improved dissolution performance of a post processing treated spray-dried crystalline solid dispersion of poorly soluble drugs. PVA
79  2015 A (polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer)-dispersed sustained-release tablet for imperialine to simultaneously prolong the drug release and improve the oral bioavailability. ---
80  2015 Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen. EGE, NAP, Tg
81  2015 Controlled porosity solubility modulated osmotic pump tablets of gliclazide. CPOP, GLZ, HME
82  2015 Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin US2. ---
83  2015 Design of modified xanthan mini-matrices for monitoring oral discharge of highly soluble Soluplus-glibenclamide dispersion. ---
84  2015 Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance. AFM, ARTM, DSC, LUMF, TGA, XRD
85  2015 Effects of preparing techniques and aging on dissolution behavior of the solid dispersions of NF/Soluplus/Kollidon SR: identification and classification by a combined analysis by FT-IR spectroscopy and computational approaches. DSC, PXRD, SEM
86  2015 Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs. CR, DSC, HPMC, PRX, SEM, XPRD
87  2015 Enhancement of docetaxel solubility using binary and ternary solid dispersion systems. DSC, DTX, FTIR, PXRD, SEM
88  2015 Improvement in antiproliferative activity of Angelica gigas Nakai by solid dispersion formation via hot-melt extrusion and induction of cell cycle arrest and apoptosis in HeLa cells. AGN, HME
89  2015 Influence of formulation technique on acrylate methacrylate copolymer modified paracetamol matrix tablets. DG
90  2015 Influence of Solid Drug Delivery System Formulation on Poorly Water-Soluble Drug Dissolution and Permeability. S-SMEDDS, S-SNEDDS
91  2015 Investigation of the solubility enhancement mechanism of rebaudioside D using a solid dispersion technique with potassium sorbate as a carrier. FT-IR, PM, Reb, SEM, XRD
92  2015 Melt dispersion granules: formulation and evaluation to improve oral delivery of poorly soluble drugs - a case study with valsartan. ---
93  2015 Molecular interaction between glimepiride and Soluplus-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies. BCS, DSC, FTIR, PEG
94  2015 Novel solid dispersions of benznidazole: preparation, dissolution profile and biological evaluation as alternative antichagasic drug delivery system. BNZ, L-HPC
95  2015 Pediatric suppositories of sulpiride solid dispersion for treatment of Tourette syndrome: in vitro and in vivo investigations. DSC, FTIR, TS, XRD
96  2015 Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers. ALG, CS, FXD, ODTs
97  2015 Physicochemical characterization and pharmacological evaluation of ezetimibe-PVP K30 solid dispersions in hyperlipidemic rats. DSC, EZT, PXRD, TC
98  2015 Poloxamer-based curcumin solid dispersions for ex tempore preparation of supersaturated solutions intended for antimicrobial photodynamic therapy. PIs
99  2015 Polymer incorporation method affects the physical stability of amorphous indomethacin in aqueous suspension. HPMC, IND, PVP, SP
100  2015 Potential use of phospholipids in combination with hydrophilic carriers for enhancement of the dissolution and oral bioavailability of imidazole antifungal Class II drugs. DMPG, DSC, KET, PXRD, SEM